Skip to main content
NCBI home page
Gut logoLink to Gut
. 1987 Feb;28(2):201–205. doi: 10.1136/gut.28.2.201

Gastrocytoprotection by colloidal bismuth subcitrate (De-Nol) and sucralfate. Role of endogenous prostaglandins.

S J Konturek, T Radecki, I Piastucki, T Brzozowski, D Drozdowicz
PMCID: PMC1432968  PMID: 3470240

Abstract

This study compares the gastroprotective effects of colloidal bismuth subcitrate (De-Nol) with those of sucralfate and a methylated analogue of prostaglandin E2 (PGE2) against acute gastric lesions induced by acidified aspirin and absolute ethanol in rats. Both De-Nol and sucralfate given orally prevented dose dependently the formation of gastric lesions by these ulcerogens, De-Nol being, respectively, twice and seven times more potent, on a weight basis, than sucralfate. As the gastroprotective activities of both De-Nol and sucralfate on ethanol lesions can be reversed by pretreatment with indomethacin and as De-Nol and sucralfate increase the mucosal generation and luminal release of PGE2, we postulate that mucosal prostaglandins may be involved in the mechanism of action of these drugs on the gastric mucosa.

Full text

PDF
201

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Hamilton I., O'Connor H. J., Wood N. C., Bradbury I., Axon A. T. Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine. Gut. 1986 Jan;27(1):106–110. doi: 10.1136/gut.27.1.106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hollander D. Efficacy of sucralfate for duodenal ulcers: a multicenter, double-blind trial. J Clin Gastroenterol. 1981;3(Suppl 2):153–157. [PubMed] [Google Scholar]
  3. Hollander D., Tarnawski A., Krause W. J., Gergely H. Protective effect of sucralfate against alcohol-induced gastric mucosal injury in the rat. Macroscopic, histologic, ultrastructural, and functional time sequence analysis. Gastroenterology. 1985 Jan;88(1 Pt 2):366–374. doi: 10.1016/s0016-5085(85)80191-8. [DOI] [PubMed] [Google Scholar]
  4. Kang J. Y., Piper D. W. Cimetidine and colloidal bismuth in treatment of chronic duodenal ulcer. Comparison of initial healing and recurrence after healing. Digestion. 1982;23(2):73–79. doi: 10.1159/000198690. [DOI] [PubMed] [Google Scholar]
  5. Konturek S. J., Brzozowski T., Piastucki I., Dembinski A., Radecki T., Dembinska-Kiec A., Zmuda A., Gregory H. Role of mucosal prostaglandins and DNA synthesis in gastric cytoprotection by luminal epidermal growth factor. Gut. 1981 Nov;22(11):927–932. doi: 10.1136/gut.22.11.927. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Konturek S. J., Brzozowski T., Piastucki I., Radecki T. Prevention of ethanol and aspirin-induced gastric mucosal lesions by paracetamol and salicylate in rats: role of endogenous prostaglandins. Gut. 1982 Jun;23(6):536–540. doi: 10.1136/gut.23.6.536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Konturek S. J. Gastric cytoprotection. Scand J Gastroenterol. 1985 Jun;20(5):543–553. doi: 10.3109/00365528509089694. [DOI] [PubMed] [Google Scholar]
  8. Konturek S. J., Piastucki I., Brzozowski T., Radecki T., Dembińska-Kieć A., Zmuda A., Gryglewski R. Role of prostaglandins in the formation of aspirin-induced gastric ulcers. Gastroenterology. 1981 Jan;80(1):4–9. [PubMed] [Google Scholar]
  9. Lavy U. I., Koekkoek P. H., Jaitly K. D. Anti-ulcer activity of colloidal bismuth subcitrate in Shay-rats. Arch Int Pharmacodyn Ther. 1976 Dec;224(2):291–298. [PubMed] [Google Scholar]
  10. Lee F. I., Samloff I. M., Hardman M. Comparison of tri-potassium di-citrato bismuthate tablets with ranitidine in healing and relapse of duodenal ulcers. Lancet. 1985 Jun 8;1(8441):1299–1302. doi: 10.1016/s0140-6736(85)92793-x. [DOI] [PubMed] [Google Scholar]
  11. Lee S. P. A potential mechanism of action of colloidal bismuth subcitrate: diffusion barrier to hydrochloric acid. Scand J Gastroenterol Suppl. 1982;80:17–21. [PubMed] [Google Scholar]
  12. Marshall B. J., McGechie D. B., Rogers P. A., Glancy R. J. Pyloric Campylobacter infection and gastroduodenal disease. Med J Aust. 1985 Apr 15;142(8):439–444. doi: 10.5694/j.1326-5377.1985.tb113444.x. [DOI] [PubMed] [Google Scholar]
  13. McHardy G. G. A multicenter, double-blind trial of sucralfate and placebo in duodenal ulcer. J Clin Gastroenterol. 1981;3(Suppl 2):147–152. [PubMed] [Google Scholar]
  14. Okabe S., Takeuchi K., Kunimi H., Kanno M., Kawashima M. Effects of an antiulcer drug, sucralfate (a basic aluminum salt of sulfated disaccharide), on experimental gastric lesions and gastric secretion in rats. Dig Dis Sci. 1983 Nov;28(11):1034–1042. doi: 10.1007/BF01311733. [DOI] [PubMed] [Google Scholar]
  15. Wieriks J., Hespe W., Jaitly K. D., Koekkoek P. H., Lavy U. Pharmacological properties of colloidal bismuth subcitrate (CBS, DE-NOL). Scand J Gastroenterol Suppl. 1982;80:11–16. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES